Literature DB >> 2168142

Mechanism of action of lomefloxacin.

L J Piddock1, M C Hall, R Wise.   

Abstract

The inhibition of supercoiling activity of reconstituted Escherichia coli DNA gyrase by lomefloxacin, ciprofloxacin, and norfloxacin was determined. The concentrations of quinolones needed to inhibit DNA synthesis in Escherichia coli, Enterobacter cloacae, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were also measured. The kinetics of uptake of [14C]lomefloxacin and unlabeled lomefloxacin into whole cells of E. coli KL-16 and S. aureus NCTC 8532 and the induction of RecA in E. coli GC2241 were assayed. All strains had wild-type susceptibilities to quinolones. The concentration of quinolones needed to inhibit DNA synthesis by 50% correlated with the MIC for members of the family Enterobacteriaceae and P. aeruginosa. The concentration of quinolones needed to inhibit DNA synthesis by 50% for late-logarithmic-phase S. aureus also correlated with the MIC, unlike the data from early-logarithmic-phase cultures. E. coli and S. aureus showed a similar pattern of uptake kinetics of [14C]lomefloxacin and unlabeled lomefloxacin, indicating that the difference in the susceptibilities of the two species is probably due to different target site affinities. Essentially, lomefloxacin was less active than ciprofloxacin and ofloxacin and had activity similar to those of norfloxacin and enoxacin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168142      PMCID: PMC171763          DOI: 10.1128/AAC.34.6.1088

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Tryptic fragments of the Escherichia coli DNA gyrase A protein.

Authors:  R J Reece; A Maxwell
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

2.  The accumulation of five quinolone antibacterial agents by Escherichia coli.

Authors:  J M Diver; L J Piddock; R Wise
Journal:  J Antimicrob Chemother       Date:  1990-03       Impact factor: 5.790

3.  In vitro and in vivo activity of NY-198, a new difluorinated quinolone.

Authors:  T Hirose; E Okezaki; H Kato; Y Ito; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Genetic control of DNA initiation in Escherichia coli.

Authors:  W H Schubach; J D Whitmer; C I Davern
Journal:  J Mol Biol       Date:  1973-02-25       Impact factor: 5.469

5.  Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins.

Authors:  K Mizuuchi; M Mizuuchi; M H O'Dea; M Gellert
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

6.  Pharmacokinetics and tissue penetration of orally administered lomefloxacin.

Authors:  J W Stone; J M Andrews; J P Ashby; D Griggs; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

7.  Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.

Authors:  D M Benbrook; R V Miller
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Fluorometric assay for fleroxacin uptake by bacterial cells.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

9.  In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.

Authors:  R Wise; J M Andrews; J P Ashby; R S Matthews
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

10.  Quantitative evaluation of recA gene expression in Escherichia coli.

Authors:  S Casaregola; R D'Ari; O Huisman
Journal:  Mol Gen Genet       Date:  1982
  10 in total
  9 in total

Review 1.  Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A N Wadworth; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

2.  Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.

Authors:  L J Piddock; M Zhu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Cultivation in Space Flight Produces Minimal Alterations in the Susceptibility of Bacillus subtilis Cells to 72 Different Antibiotics and Growth-Inhibiting Compounds.

Authors:  Michael D Morrison; Patricia Fajardo-Cavazos; Wayne L Nicholson
Journal:  Appl Environ Microbiol       Date:  2017-10-17       Impact factor: 4.792

Review 4.  New quinolones and gram-positive bacteria.

Authors:  L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 5.  Lomefloxacin clinical pharmacokinetics.

Authors:  C D Freeman; D P Nicolau; P P Belliveau; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

6.  Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.

Authors:  M Tanaka; K Sato; Y Kimura; I Hayakawa; Y Osada; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 7.  Mode of action of the new quinolones: new data.

Authors:  D C Hooper; J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

8.  Efficacy and safety of lomefloxacin on bacterial extraocular disease in the horse.

Authors:  Shuhei Hidaka; Mitsutoshi Kobayashi; Kunihide Ando; Yoshikazu Fujii
Journal:  J Vet Med Sci       Date:  2015-03-15       Impact factor: 1.267

9.  The anticoccidial activity of the fluoroquinolone lomefloxacin against experimental Eimeria tenella infection in broiler chickens.

Authors:  Kamal Ahmed El-Shazly; Amera Abd El-Latif; Walied Abdo; Ahmed El-Morsey; Magdy Ibrahim Abd El-Aziz; Heba El-Mogazy
Journal:  Parasitol Res       Date:  2020-05-13       Impact factor: 2.289

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.